How relevant are GFAP autoantibodies in autism and Tourette syndrome?

Journal of Autism and Developmental Disorders

Volumn 38, Issue 2, 2008, Pages 333-341

  Kirkman, Nikki J ^a   Libbey, Jane E ^a   Sweeten, Thayne L ^a   Coon, Hilary H ^a   Miller, Judith N ^a   Stevenson, Edward K ^a   Lainhart, Janet E ^a   McMahon, William M ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Autoantibody; Glial fibrillary acidic protein; Immunoglobulin; Tourette Syndrome

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WESTERN BLOTTING;

AUTISTIC DISORDER; AUTOANTIBODIES; BRAIN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; REFERENCE VALUES; TOURETTE SYNDROME;

EID: 38549179973     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-007-0398-9     Document Type: Article

References (50)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Text Revision. Washington, DC.
2. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995). Autism as a strongly genetic disorder: Evidence from a British twin study. Psychology of Medicine, 25, 63-77.
3. Borenstein, M., Rothstein, H., & Cohen, J. (2000). Power and Precision, version 2.0. www.PowerAndPrecision.com.
4. Chakrabarti, S., & Fombonne, E. (2001). Pervasive developmental disorders in preschool children. Journal of the American Medical Association, 285, 3093-3099.
5. Coleman, M., & Gillberg, C. (1985). The biology of the autistic syndromes. New York: Praeger Publishers.
6. Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., & Peeden, J. N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology, 14, 388-394.
7. Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics, 134, 607-613.
8. Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Van de Water, J. (2005). Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Archives of Pediatrics, & Adolescent Medicine, 159, 151-157.
9. Dahl, D., Crosby, C. J., Gardner, E. E., & Bignami, A. (1982). Purification of the glial fibrillary acidic protein by anion-exchange chromatography. Analytical Biochemistry, 126, 165-169.
10. Eng, L. F., Ghirnikar, R. S., & Lee, Y. L. (2000). Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochemical Research, 25, 1439-1451.
11. Fombonne, E. (2003). The prevalence of autism. Journal of the American Medical Association, 289, 87-89.
12. Fujinami, R. S., Zurbriggen, A., & Powell, H. C. (1988). Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. Journal of Neuroimmunology, 20, 25-32.
13. Gillberg, C., & Wing, L. (1999). Autism: Not an extremely rare disorder. Acta Psychiatra Scandinavica, 99, 399-406.
14. Goldberg, W. A., Osann, K., Filipek, P. A., Laulhere, T., Jarvis, K., Modahl, C., Flodman, P., & Spence, M. A. (2003). Language and other regression: assessment and timing. Journal of Autism and Developmental Disorders, 33, 607-616.
15. Hallett, J. J., Harling-Berg, C. J., Knopf, P. M., Stopa, E. G., & Kiessling, L. S. (2000). Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. Journal of Neuroimmunology, 111, 195-202.
16. Hickey, W. F. (2001). Basic principles of immunological surveillance of the normal central nervous system. Glia, 36, 118-124.
17. Jankovic, J. (2001). Tourette's syndrome. New England Journal of Medicine, 345, 1184-1192.
18. Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., Williamson, D., & Ryan, N. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 980-988.
19. Kiessling, L. S., Marcotte, A. C., & Culpepper, L. (1993). Antineuronal antibodies in movement disorders. Pediatrics, 92, 39-43.
20. Lee, L. C., Zachary, A. A., Leffell, M. S., Newschaffer, C. J., Matteson, K. J., Tyler, J. D., & Zimmerman, A. W. (2006). HLA-DR4 in families with autism. Pediatric Neurology, 35, 303-307.
21. Loiselle, C. R., Lee, O., Moran, T. H., & Singer, H. S. (2004). Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Movement Disorders, 19, 390-396.
22. Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Jr., Leventhal, B. L., DiLavore, P. C., Pickles, A., & Rutter, M. (2000). The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30, 205-223.
23. Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659-685.
24. Luyster, R., Richler, J., Risi, S., Hsu, W.-L., Dawson, G., Bernier, R., Dunn, M., Hepburn, S., Hyman, S. L., McMahon, W. M., Goudie-Nice, J., Minshew, N., Rogers, S., Sigman, M., Spence, M. A., Goldberg, W. A., Tager-Flusberg, H., Volkmar, F. R., & Lord, C. (2005). Early regression in social communication in autism spectrum disorders: A CPEA Study. Developmental Neuropsychology, 27, 311-336.
25. Meinl, E., Krumbholz, M., & Hohlfeld, R. (2006). B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Annals of Neurology, 59, 880-892.
26. Nelson, K. B. (1991). Prenatal and perinatal factors in the etiology of autism. Pediatrics, 87, 761-766.
27. Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E. (1994). Immunoglobin reactivity in autism and Rett's syndrome. Developmental Brain Dysfunction, 7, 12-16.
28. Sambrook, J., Fritsch, E. F., & Maniatis, T. (1989). Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory.
29. Schotte, A., Janssen, P. F., Megens, A. A., & Leysen, J. E. (1993). Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research, 631, 191-202.
30. Silva, S. C., Correia, C., Fesel, C., Barreto, M., Coutinho, A. M., Marques, C., Miguel, T. S., Ataide, A., Bento, C., Borges, L., Oliveira, G., & Vicente, A. M. (2004). Autoantibody repertoires to brain tissue in autism nuclear families. Journal of Neuroimmunology, 152, 176-182.
31. Singer, H. S., Giuliano, J. D., Hansen, B. H., Hallett, J. J., Laurino, J. P., Benson, M., & Kiessling, L. S. (1998). Antibodies against human putamen in children with Tourette syndrome. Neurology, 50, 1618-1624.
32. Singer, H. S., Mink, J. W., Loiselle, C. R., Burke, K. A., Ruchkina, I., Morshed, S., Parveen, S., Leckman, J. F., Hallett, J. J., & Lombroso, P. J. (2005). Microinfusion of antineuronal antibodies into rodent striatum: failure to differentiate between elevated and low titers. Journal of Neuroimmunology, 163, 8-14.
33. Singer, H. S., Morris, C. M., Williams, P. N., Yoon, D. Y., Hong, J. J., & Zimmerman, A. W. (2006). Antibrain antibodies in children with autism and their unaffected siblings. Journal of Neuroimmunology, 178, 149-155.
34. Singh, V. K., & Rivas, W. H. (2004). Prevalence of serum antibodies to caudate nucleus in autistic children. Neuroscience Letters, 355, 53-56.
35. Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997). Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatric Neurology, 17, 88-90.
36. Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain Behavior and Immunity, 7, 97-103.
37. Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Lougee, L., Dow, S., Zamkoff, J., & Dubbert, B. K. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. American Journal of Psychiatry, 155, 264-271.
38. Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., & McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112, e420.
39. Taylor, J. R., Morshed, S. A., Parveen, S., Mercadante, M. T., Scahill, L., Peterson, B. S., King, R. A., Leckman, J. F., & Lombroso, P. J. (2002). An animal model of Tourette's syndrome. American Journal of Psychiatry, 159, 657-660.
40. Todd, R. D., Hickok, J. M., Anderson, G. M., & Cohen, D. J. (1988). Antibrain antibodies in infantile autism. Biological Psychiatry, 23, 644-647.
41. Tolley, N. D., Tsunoda, I., & Fujinami, R. S. (1999). DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. Journal of Virology, 73, 993-1000.
42. Torres, A. R., Maciulis, A., Stubbs, E. G., Cutler, A., & Odell, D. (2002). The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Human Immunology, 63, 311-316.
43. Torres, A. R., Sweeten, T. L., Cutler, A., Bedke, B. J., Fillmore, M., Stubbs, E. G., & Odell, D. (2006). The association and linkage of the HLA-A2 class I allele with autism. Human Immunology, 67, 346-351.
44. Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67-81.
45. Vojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. (2002). Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. Journal of Neuroimmunology, 129, 168-177.
46. Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., & Torres, A. R. (1996). Strong association of the third hypervariable region of HLA-DR β1 with autism. Journal of Neuroimmunology, 67, 97-102.
47. Yamada, M., Zurbriggen, A., Oldstone, M. B. A., & Fujinami, R. S. (1991). Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. Journal of Virology, 65, 1370-1376.
48. Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. Journal of the American Medical Association, 289, 49-55.
49. Yeh, C. -B., Wu, C. -H., Tsung, H. -C., Chen, C. -W., Shyu, J. -F., & Leckman, J. F. (2006). Antineural antibody in patients with Tourette's syndrome and their family members. Journal of Biomedical Science, 13, 101-112.
50. Zimmerman, A. W., Connors, S. L., Matteson, K. J., Lee, L. C., Singer, H. S., Castaneda, J. A., & Pearce, D. A. (2007). Maternal antibrain antibodies in autism. Brain Behavior and Immunity, 21, 351-357.